肝切除术与立体定向体部放疗治疗早期小肝癌的倾向匹配分析
该单中心回顾性研究纳入2008至2015年281例1–3个直径≤3 cm小肝癌患者(手术254例,立体定向体部放疗27例),倾向匹配后比较54例手术与27例放疗。多因素分析显示手术是总生存和无病生存的有利因素。
要点
- 立体定向体部放疗可作为不可手术早期肝癌患者的有效替代治疗。
核心结论
- 对于1–3个直径≤3 cm的小肝癌,手术切除提供了更好的长期总生存和无病生存。
- 立体定向体部放疗可能是不可手术早期肝癌患者的有效替代治疗。
研究设计与样本
- 单中心回顾性分析,2008至2015年共281例1–3个直径≤3 cm小肝癌患者,初始根治性治疗(手术254例,立体定向体部放疗27例)。
- 采用倾向评分匹配分析比较总生存和无病生存。
主要发现
- 手术组患者更年轻、肿瘤数目更多、肝功能更好(P < .05)。
- 放疗组同亚段复发比例显著高于手术组(P = .0034)。
- 倾向匹配后54例手术与27例放疗基线特征一致,5年总生存率75.2% vs 47.8%(P = .0149),无病生存率33.8% vs 16.4%(P = .0512)。
- 多因素分析显示手术切除是1–3个小肝癌患者总生存和无病生存的显著有利因素。
临床怎么用
- 对于可手术的早期小肝癌(1–3个,直径≤3 cm),优先考虑手术切除以改善长期生存。
- 对于不可手术的早期肝癌患者,立体定向体部放疗可作为替代治疗选择。
局限性
- 单中心回顾性研究,样本量有限,放疗组仅27例,可能存在选择偏倚。
- 倾向匹配后样本量较小(手术54例,放疗27例),统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of both surgical resection and stereotactic body radiotherapy for small hepatocellular carcinoma. BACKGROUND: Although the number of stereotactic body radiotherapies being performed for hepatocellular carcinoma has gradually increased, data comparing surgical resection and stereotactic body radiotherapy are limited. METHODS: Between 2008 and 2015, a total of 281 patients with 1 to 3 small hepatocellular carcinoma tumors (≤3 cm in diameter), treated initially with curative intent (surgical resection, 254; stereotactic body radiotherapy, 27), were retrospectively analyzed. Overall survival and disease-free survival were compared in a propensity score matching analysis. RESULTS: Patients in the surgical resection group tended to be younger, had more tumors, and had better hepatic function than those in the stereotactic body radiotherapy group (P < .05). The percent recurrence of the same sub-segment in the stereotactic body radiotherapy group was significantly higher than that in the surgical resection group (P = .0034). Propensity score analysis revealed that 54 patients with surgical resection and 27 with stereotactic body radiotherapy had the same baseline characteristics. The 5-year overall survival and disease-free survival rates for the surgical resection and stereotactic body radiotherapy groups were 75.2% vs 47.8% (P = .0149) and 33.8% vs 16.4% (P = .0512), respectively. Multivariate analysis showed that surgical resection was a significant favorable factor for overall survival and disease-free survival of patients with one to three small hepatocellular carcinomas. CONCLUSION: Surgical resection provided better long-term overall survival and disease-free survival in patients with small hepatocellular carcinoma tumors. However, stereotactic body radiotherapy may be an effective alternative treatment for inoperable patients with early hepatocellular carcinoma.
引用
- Nakano R, Ohira M, Kobayashi T, et al. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution. Surgery. 2018. PMID: 29801728. doi:10.1016/j.surg.2018.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。